about
Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic woundsBiofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections.Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds.Success rate of split-thickness skin grafting of chronic venous leg ulcers depends on the presence of Pseudomonas aeruginosa: a retrospective study.Antibiofilm Properties of Acetic AcidWhy chronic wounds will not heal: a novel hypothesis.ESCMID guideline for the diagnosis and treatment of biofilm infections 2014.Preoperative blood glucose and prognosis in diabetic patients undergoing lower extremity amputation.Clinical management of acute diabetic Charcot foot in Denmark.The management of diabetic foot ulcers in Danish hospitals is not optimal.Distribution, organization, and ecology of bacteria in chronic woundsProgression of disease preceding lower extremity amputation in Denmark: a longitudinal registry study of diagnoses, use of medication and healthcare services 14 years prior to amputation.[Accidents caused by inflatable bouncers in 0-19 year-olds in Denmark in 1993][Clinical result after Leeds-Keio reconstruction of the anterior cruciate ligament].Pseudomonas aeruginosa transcriptome during human infection.The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods.Perioperative AntibioticsPerioperative AntibioticsAn exercise program for people with severe peripheral neuropathy and diabetic foot ulcers - a case series on feasibility and safetySilver against Pseudomonas aeruginosa biofilms[Acute compartment syndrome after a brief march][Bacterial biofilm in chronic wounds][Suspected anaphylaxis by wound treatment with polyhexanide derivate wound products]Non-antibiotic antimicrobial interventions and antimicrobial stewardship in wound careExsanguination of lower limbs in healthy male subjectsThe Zone Model: A conceptual model for understanding the microenvironment of chronic wound infection
P50
Q33509271-D69CF82C-16DA-48D6-A1E6-19CA5269424BQ33625314-CBF1D46B-F36B-47AE-B446-13C5DBE178EAQ33881502-C23ADD59-EC75-4063-A2CD-B6D0E19AF28BQ33927203-A90BDB10-E616-4ED3-9362-8CDB739C9F22Q35801616-C5F296C2-E322-4F33-882B-7FC4EBEB8A67Q37062464-8600A25D-CFE6-4E80-870A-FABDF85193A1Q39055760-1F943E53-BAC7-4667-BF26-49226C6B092CQ39872841-D1C02DB5-60AA-4101-A455-7558FABE6108Q40556234-F606F160-AC02-4120-B733-3C61020113BAQ40876455-B51FFC6D-C37D-4278-95B1-BE0CBF59BE8EQ42406600-205A42C1-41C9-4EC0-960B-CC46D83D7B8EQ47119782-94BADF1C-36F5-4666-AA17-A4625FEB27E0Q50559312-5B58B8D2-2452-4AB2-8E33-1790CC47D124Q52872800-B607E368-33A7-40BB-9892-D357784D8433Q54212212-0E00BCEB-1F03-4123-A629-38EEADCA3441Q54445943-D696705A-8490-4CB8-89B9-2A704EFA9787Q56928142-FD5A893C-C28E-4B85-8325-AEC54FB2BA82Q56928143-50370BA5-68ED-4479-A5D1-386C0800FC57Q57182598-6E0659D2-6B14-4EAC-A584-6BD42972DD98Q59139141-D9F3A1E8-3E33-432B-A170-7011F57B73BCQ67923420-5365A0CC-AE9F-4F02-8C10-3ECB89411AA8Q83556744-21824D23-EB49-463D-B412-39FD1E802A0EQ86253462-8D66DBA0-1E8F-4A03-891C-6BF5670D3ADEQ89042027-91002561-32A8-4052-93EC-49F20CB47A85Q94045310-B05C4C3B-474B-4B0C-BB58-A545FAEC28B4Q96307087-0F1AE6C3-C80F-425D-8314-F8BE54080F51
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Klaus Kirketerp-Møller
@ast
Klaus Kirketerp-Møller
@en
Klaus Kirketerp-Møller
@es
Klaus Kirketerp-Møller
@nl
Klaus Kirketerp-Møller
@sl
type
label
Klaus Kirketerp-Møller
@ast
Klaus Kirketerp-Møller
@en
Klaus Kirketerp-Møller
@es
Klaus Kirketerp-Møller
@nl
Klaus Kirketerp-Møller
@sl
prefLabel
Klaus Kirketerp-Møller
@ast
Klaus Kirketerp-Møller
@en
Klaus Kirketerp-Møller
@es
Klaus Kirketerp-Møller
@nl
Klaus Kirketerp-Møller
@sl
P106
P21
P31
P496
0000-0002-3248-8448